China NMPA Drug Inspection - Xiaogan Dai Liquan Tongren Traditional Chinese Medicine Clinic - Smilax glabra
China NMPA drug inspection for Xiaogan Dai Liquan Tongren Traditional Chinese Medicine Clinic published November 28, 2019. Drug: Smilax glabra. The Hubei Provincial Food and Drug Administration released an announcement on August 28, 2015 (published November 28, 20
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Xiaogan Dai Liquan Tongren Traditional Chinese Medicine Clinic published November 28, 2019. Drug: Smilax glabra. The Hubei Provincial Food and Drug Administration released an announcement on August 28, 2015 (published November 28, 20
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox